Medicare Enrolled

Dr. Austin Hake, M.D.

Neurology · Quincy, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1118 HAMPSHIRE ST, Quincy, IL 62301
2172226550
In practice since 2008 (18 years)
NPI: 1003077389 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hake from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hake? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hake

Dr. Austin Hake is a neurology specialist in Quincy, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Hake performed 17,681 Medicare services across 673 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hake received a total of $31,230 from 73 pharmaceutical and/or device companies across 1030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hake is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 4% volume in IL $31,230 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,681
Medicare services
Top 4% in IL for neurology
673
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~982 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
16,800 $5 $13
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
503 $85 $287
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
112 $61 $195
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
85 $72 $326
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
77 $120 $446
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 44 $56 $254
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
21 $96 $460
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
14 $322 $1,412
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
14 $132 $587
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
11 $158 $736
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$31,230
Total received (2018-2024)
Avg $4,461/year across 7 years
Top 11% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,030
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,253 (52.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,977 (48.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,035
2023
$4,548
2022
$14,234
2021
$5,927
2020
$848
2019
$801
2018
$836

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$719
Teva Pharmaceuticals USA, Inc.
$311
UCB, Inc.
$305
Lilly USA, LLC
$304
Celgene Corporation
$250
PFIZER INC.
$236
Neurocrine Biosciences, Inc.
$187
EMD Serono, Inc.
$173
Lundbeck LLC
$155
Neurelis, Inc.
$146
ACADIA Pharmaceuticals Inc
$137
E.R. Squibb & Sons, L.L.C.
$134
ARGENX US, INC.
$128
SK Life Science, Inc.
$111
Eisai Inc.
$85
Novartis Pharmaceuticals Corporation
$75
JAZZ PHARMACEUTICALS INC.
$70
LivaNova USA, Inc.
$61
HARMONY BIOSCIENCES LLC
$47
Abbott Laboratories
$43
CATALYST PHARMACEUTICALS, INC.
$40
Sumitomo Pharma America, Inc.
$35
Amgen Inc.
$33
Genentech USA, Inc.
$33
GE HEALTHCARE
$32
Novo Nordisk Inc
$29
Ipsen Biopharmaceuticals, Inc
$27
Cycle Pharmaceuticals Inc
$25
Boston Scientific Corporation
$21
Biogen, Inc.
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Kyowa Kirin, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$15
CSL Behring
$14
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$12,924
AbbVie Inc.
$4,010
UCB, Inc.
$1,065
Amgen Inc.
$902
SK Life Science, Inc.
$857
LivaNova USA, Inc.
$848
Lilly USA, LLC
$694
Celgene Corporation
$654
Novartis Pharmaceuticals Corporation
$581
Teva Pharmaceuticals USA, Inc.
$569
PFIZER INC.
$568
Neurocrine Biosciences, Inc.
$487
ARGENX US, INC.
$468
ACADIA Pharmaceuticals Inc
$450
EMD Serono, Inc.
$444
Neurelis, Inc.
$432
Lundbeck LLC
$382
Supernus Pharmaceuticals, Inc.
$373
Genentech USA, Inc.
$350
Biohaven Pharmaceutical Holding Company Ltd.
$315
Biogen, Inc.
$285
Harmony Biosciences LLC
$283
GENZYME CORPORATION
$266
Eisai Inc.
$225
Acorda Therapeutics, Inc
$205
Allergan, Inc.
$160
E.R. Squibb & Sons, L.L.C.
$159
Impax Laboratories, Inc.
$143
Medtronic, Inc.
$120
Abbott Laboratories
$114
Allergan Inc.
$112
Medtronic USA, Inc.
$108
JAZZ PHARMACEUTICALS INC.
$102
Novo Nordisk Inc
$96
MITSUBISHI TANABE PHARMA AMERICA, INC.
$93
Sunovion Pharmaceuticals Inc.
$90
CATALYST PHARMACEUTICALS, INC.
$84
Adamas Pharmaceuticals, Inc.
$81
IMPEL PHARMACEUTICALS INC.
$77
Boston Scientific Corporation
$74
Kyowa Kirin, Inc.
$73
HARMONY BIOSCIENCES LLC
$71
Biohaven Pharmaceuticals, Inc.
$69
Otsuka America Pharmaceutical, Inc.
$61
UPSHER-SMITH LABORATORIES LLC
$57
GE HealthCare
$48
Upsher-Smith Laboratories LLC
$45
EISAI INC.
$39
Avion Pharmaceuticals
$38
Sumitomo Pharma America, Inc.
$35
GE HEALTHCARE
$32
Takeda Pharmaceuticals U.S.A., Inc.
$27
Ipsen Biopharmaceuticals, Inc
$27
ARBOR PHARMACEUTICALS, INC.
$26
Horizon Therapeutics plc
$26
Catalyst Pharmaceuticals, Inc.
$26
Cycle Pharmaceuticals Inc
$25
Avanir Pharmaceuticals, Inc.
$23
Almatica Pharma LLC
$21
Alnylam Pharmaceuticals Inc.
$19
Amarin Pharma Inc.
$19
Nestle HealthCare Nutrition Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
MDD US Operations, LLC
$16
Exeltis, USA Inc.
$16
Exact Sciences Corporation
$16
CSL Behring
$14
Jazz Pharmaceuticals Inc.
$13
BOSTON SCIENTIFIC CORPORATION
$13
Adlon Therapeutics L.P.
$13
Kowa Pharmaceuticals America, Inc.
$13
Janssen Pharmaceuticals, Inc
$13
Electromed, Inc.
$13
Top 3 companies account for 57.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACTIVA · ACTIVA PC · ADHANSIA XR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · Briviact · COMIRNATY · Cenobamate · Cologuard Collection Kit · DALVANCE · DUOPA · Dhivy · Dysport · EMGALITY · ENTRESTO · EVENITY · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEQVIO · Leqembi · Livalo · MAVENCLAD · MAYZENT · MICROSTREAM · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · Otezla · Ozempic · PAXLOVID · PERCEPT PC BRAINSENSE · PURIFIED CORTROPHIN GEL · QALSODY · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rybelsus · Rystiggo · SMARTVEST · SPIRIVA RESPIMAT · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · Tascenso ODT · Trintellix · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vascepa · Vimpat · WAKIX · WATCHMAN Access System · Wakix · WaveWriter Alpha Prime 16 · Wegovy · XARELTO · XCOPRI · XYREM · XYWAV · ZENPEP · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a neurology specialist in Quincy?
Compare neurologists in the Quincy area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
8
Per 100K population
12.3
County median income
$64,962
Nearest hospital
BLESSING HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hake is a mixed practice specialist, with above-average Medicare volume (top 4% in IL), with speaking/promotional industry engagement in the top 11% of IL peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hake experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Hake performed 16,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hake receive payments from pharmaceutical companies?
Yes. Dr. Hake received a total of $31,230 from 73 companies across 1,030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hake's costs compare to other neurologists in Quincy?
Dr. Hake's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hake) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →